KLF4 promotes apoptosis evasion and PARP inhibitor resistance in BRCA2-mutated epithelial ovarian cancer
Esma Fera, Tiffany Zhang, Victoria Grechukhina, Yong-Lian Zhu, Elena Ratner, Z. Ping Lin
This study identifies KLF4 as a driver of apoptosis evasion and PARP inhibitor resistance in BRCA2-mutated ovarian cancer, showing that targeting KLF4 enhances olaparib efficacy.
bioRxiv · Aug 24, 2026 · PreprintCancer Biology